TruthArchive.ai - Related Video Feed

If a genetic sequence is injected that causes the body to manufacture a foreign protein, the body recognizes it as an invasion and launches an attack on cells. This autoimmune reaction can occur anywhere the injection lands, potentially causing myocarditis or a heart attack if it lands in the heart, stroke or neurological conditions if in the brain, blindness if in the eyes, or sterilization if in the ovaries. The body is being made to manufacture something that does not belong in it. The speaker believes the so-called vaccines encode spike proteins, which are acutely toxic to blood cells, prompting blood clots, and to nerve cells, causing them to malfunction. The body is forced to make something directly toxic, intentionally. The injectables are wrapped in lipid nanoparticles.

The Pfizer shot contains synthetic messenger RNA that stays in the body indefinitely, unable to be detoxed. It destroys toll-like receptors 3, 7, and 8, which are crucial for our immune system's defense against viruses and bacteria. This makes vaccinated individuals more susceptible to COVID-19. The spike protein from the shot enters the cell nucleus, binds to DNA, and blocks repair enzymes, potentially leading to cancer. There is evidence of an increase in cancer cases among vaccinated individuals. Multiple shots further weaken the immune system, with German data suggesting that by the end of 2022, fully vaccinated individuals over 30 may have immune suppression similar to AIDS.

Dr. Pretorius and a colleague discuss unusual clotting observed after COVID-19 vaccination, including embalmers reporting back pressure when introducing embalming fluid and the extraction of very long, congealed clots—six inches to several feet—as well as patients with long brachial clots. They note thousands of clotting reports in VAERS across all vaccine types, describing these clots as not normal. Some clots cause major emboli affecting circulation to the lungs, detected by scans and perfusion studies, while others are microclots with a branching pattern visible in imaging. A clinician also shared a photo of a clot with a complete branching pattern into medium and smaller vessels. Dr. Pretorius’ work is cited to explain the mechanism: spike protein can induce immediate clumping of proteins in platelet-poor plasma in the absence of platelets, a highly unusual clotting pathway not relying on the classical coagulation cascade. This is described as a proteinaceous, pseudo-amyloid–like clot. The spike protein is reported to circulate after vaccination, with studies in the Journal of Immunology showing spikes in circulation and exosomes up to four months after shots. Long-haul COVID data (Patterson’s study) reportedly shows S1 protein present in nonclassical monocytes in blood, suggesting persistence of spike protein, whether from infection or the vaccine, which can induce clotting pathways on its own. Dr. Pretorius discusses observations of upregulation of intercellular adhesion molecules (ICAMs) on leukocytes within clots, causing white blood cells to adhere in addition to fibrin, contributing to difficulty in dissolving these clots. Concerning treatment and detection, the speakers describe depletion of plasminogen, reducing the body’s ability to break down clots, and note that standard anticoagulants are less effective against these clots, which are described as amyloid-like and atypical. They emphasize that these are not the classical clotting pathways involving platelet activation and typical thrombin–fibrin cascades. They contrast this with expectations of standard clotting mechanisms and reference the unusual, non-classical pathway highlighted by Pretorius. The discussion also mentions the idea that spike protein in circulation can drive clotting without the usual platelet activation, and that some patients have continued to experience spike-related effects long after vaccination. They assert that vaccines were developed targeting the original Wuhan strain and may not cover Omicron; they suggest the shot’s risk-benefit balance is unfavorable given ongoing clotting, immune suppression, and cancer-inducing pathways, and they claim data indicate those who receive two or three shots may acquire Omicron at a higher rate than those unvaccinated. They conclude that the shot is expired for a virus that is no longer circulating in its original form and argue that vaccination induces dangerous pathologic processes with no protective benefit.

Bonjour à tous, Anaïs Bloqué, docteur en biologie santé, explique les impacts de la protéine Spike du SARS-CoV-2 sur le système immunitaire inné, basés sur son article récent. La Spike seule n'active pas complètement le TLR 4, un récepteur immunitaire, et ne permet pas la production d'interférons de type 1, essentiels pour lutter contre le virus. Pour une activation complète, la Spike doit s'associer au LPS (des bactéries gram négatifs). L'activation des interférons 1 augmente l'expression d'ACE2, le récepteur du virus, sensibilisant l'organisme à l'infection. Les interférons 1 peuvent aussi être activés par les RLR, notamment MDA5, qui détecte l'ARN messager modifié des vaccins anti-COVID. De plus, la Spike, protéine amyloïde, peut déclencher le TLR 4 en s'associant aux fibres amyloïdes A bêta 42, créant un "double effet amyloïde". L'augmentation de NF-κB par les interférons 1 peut bloquer la p53, un suppresseur de tumeur, et induire l'expression du MIR-29b, qui bloque ACE2. Chez les personnes avec comorbidités, ayant déjà de faibles niveaux d'ACE2, cette interaction Spike-LPS devient dangereuse, créant une boucle d'amplification inflammatoire. La Spike persiste longtemps dans l'organisme, et avec ses propriétés amyloïdes, pourrait entraîner des pathologies dégénératives à long terme. --- Hello everyone, Anaïs Bloqué, Doctor of Philosophy in Health Biology, explains the impacts of the SARS-CoV-2 Spike protein on the innate immune system, based on her recent article. The Spike alone does not fully activate TLR 4, an immune receptor, and does not allow the production of type 1 interferons, which are essential for fighting the virus. For complete activation, the Spike must associate with LPS (from gram-negative bacteria). Activation of interferon 1 increases the expression of ACE2, the virus's receptor, sensitizing the body to infection. Interferons 1 can also be activated by RLRs, in particular MDA5, which detects the modified messenger RNA of anti-COVID vaccines. In addition, Spike, an amyloid protein, can trigger TLR 4 by associating with amyloid A beta 42 fibers, creating a "double amyloid effect". The increase in NF-κB by interferons 1 can block p53, a tumor suppressor, and induce the expression of MIR-29b, which blocks ACE2. In people with comorbidities, who already have low levels of ACE2, this Spike-LPS interaction becomes dangerous, creating an inflammatory amplification loop. Spike persists in the body for a long time, and with its amyloid properties, could lead to long-term degenerative pathologies.

Professor Jean-Marc Sabatier's recent study sheds light on the toxicity of the Spike protein produced by mRNA vaccines. This protein disrupts the renin-angiotensin system in our organs, leading to numerous side effects. The Spike protein also affects the anti-oncogenic protein p53, which repairs damaged DNA. By inhibiting DNA repair, the Spike protein can contribute to the development of autoimmune diseases and cancers, even years after vaccination. The proposed remedy, the vaccine, is deemed more dangerous than the potential harm it aims to prevent, especially since it does not protect against reinfection or transmission. Despite personal convictions, the speaker remains in their position as a doctor and parent to protect their children and patients from complications and allow them to continue their education and work.

Je suis Anaïs Bloqué, docteur en biologie, expliquant les impacts de la protéine Spike du SARS-CoV-2 sur le système immunitaire. La Spike seule ne déclenche pas la production d'interférons de type 1, nécessitant une association avec le LPS pour activer le TLR4. Cette interaction peut augmenter l'expression d'ACE2, favorisant l'infection virale. Des boucles inflammatoires complexes peuvent se former, menant à des conséquences potentiellement dangereuses, surtout chez les individus avec des comorbidités. La persistance de la protéine Spike dans l'organisme peut entraîner des problèmes dégénératifs à long terme.

The spike protein may inhibit tumor suppressor genes like MHS 3p53 and BRCA2, potentially leading to cancer. The mRNA vaccine contains a base that allows the spike protein to be produced for longer, possibly further inhibiting tumor suppressor genes. Concerns are raised about the long-term effects of these vaccines, with a call for them to be banned for general use and reserved for gene therapy in advanced cancer cases.

Je suis Anaïs Bocquet, biologiste et enseignante. La protéine Spike active les récepteurs TLR 4 et 2, déclenchant des réponses inflammatoires. L'IL-10 régule l'immunité, tandis que les alarmines activent les cellules mdsc pour inhiber la réponse immunitaire. L'IL-10 favorise la surexpression de ACE2 et la production d'IgG4 anti-inflammatoires. L'activation de TLR 2 inhibe les TLR 7 et 9, stoppant la réponse aux interférons de type 1. La persistance de Spike favorise la tolérance immunitaire, augmentant la sensibilité aux infections virales. Le TLR 4 est crucial dans la bascule entre inflammation et tolérance. En résumé, Spike manipule l'immunité pour favoriser la pathogénèse virale.

"Now, when these genes, packages, enter the cells, then the cells will start making this damn virus protein which is called the spike." "This is going to happen to any mRNA or gene based vaccine." "Those packages are going to cause your cells in the blood vessels to create this protein and this protein is going to be a foreign non self protein that is going to be recognised by any antibodies that you have and these antibodies are going to be there after the first injection." "If any of these vessels is clogged because of a thrombus or because it's injured, the cells that are being supplied by oxygen are going to die." "So if these tiny vessels in the brain or the heart are damaged, you are damaged for life. You will never be the same again."

Cette vidéo résume: selon Nakaoota et al. (3 avril 2025), « l’expression de la protéine Spike chez 43.8 pour 100 des personnes vaccinées anti Covid » persiste « au niveau des artères coronaires » jusqu’à 17 mois après l’injection, avec « l’ARN messager, du vaccin, mais également du virus » détecté. Il y a « persistance de la protéine Spike » et « persistance du SARS-CoV-2 » possiblement malgré les traitements précoces. L’auteure mentionne aussi « Crüssfeld Jacob, 14 mois après infection » et une étude sur des « AVC 17 mois après injections ». L’interaction de la nucléocapside (protéine N) avec TRIM28 pourrait retarder la réponse immunitaire innée, renforçant la tolérance immunitaire via TLR2/RAGE et IgG4. Conséquences: infection potentiellement asymptomatique et dégâts cumulatifs; Spike persistante pourrait entraîner « spike viral plus spike vaccinal ». Des spycopathies neurologiques sont évoquées; dépistage de Spike et traque du virus recommandés; traitements personnalisés et soutien par curcumine, quercétine, vitamine D; approche individuelle. This video summarizes: according to Nakaoota et al. (April 3, 2025), « the expression of the spike protein in 43.8 per 100 of vaccinated people » persists « at the level of the coronary arteries » for up to 17 months after injection, with « mRNA from the vaccine, but also the virus » detected. There is « persistence of the Spike protein » and « persistence of SARS-CoV-2 » possibly despite early treatments. The author also cites « Crüssfeld Jacob, 14 months after infection » and a study on « strokes 17 months after injections ». The interaction of the nucleocapsid protein (N) with TRIM28 could delay the innate antiviral response, reinforcing immune tolerance via TLR2/RAGE and IgG4. Consequences: potentially asymptomatic infection and cumulative damage; persistent Spike could lead to « spike viral plus spike vaccinal ». Neurological spycopathies are discussed; diagnostics to detect Spike and tracking the virus are recommended; therapies to block/remove Spike and personalized approaches, with supports like curcumin, quercetin, vitamin D.

The speaker explains that the SARS CoV-2 virus, which causes COVID-19, has been successfully isolated and observed under a microscope. They show how the virus affects the lungs, causing scar tissue and disrupting blood flow. The virus enters the body through the ACE2 receptors and triggers an inflammatory pathway, leading to complications. The speaker highlights that the virus affects blood vessels throughout the body, including the brain, heart, lungs, kidneys, and GI tract. This widespread damage occurs due to the activation of the AT1R pathway, which triggers various inflammatory cells and molecules. Overall, COVID-19 damages multiple organs by instigating an internal battle within the blood vessels.

The Pfizer vaccine uses synthetic messenger RNA that replicates indefinitely in cells, making it impossible to detoxify from it. This mRNA damages toll-like receptors 3, 7, and 8, which are crucial for the innate immune response, increasing susceptibility to infections like COVID. Consequently, vaccinated individuals are more likely to become ill and face higher hospitalization rates. The spike protein can bind to DNA, potentially leading to abnormal cell growth and cancer, which explains the rise in various cancers among vaccinated individuals. Recent data indicates that vaccinated people are significantly more likely to contract omicron, and ongoing vaccinations may lead to severe immune suppression, comparable to AIDS, particularly in those over 30.

The spike protein, according to research in South Africa, induces fibrin from fibrinogen, forming the backbone of clotting in a way not previously seen. Unlike normal fibrin clots that are easily broken down, clots formed from COVID or the spike protein from the vaccine are difficult to break down, causing issues for many people. A cardiologist stated that in their decades of practice, they have never treated as many blood clots as in the last five years. These blood clots occur after the virus infection and the vaccine because the spike protein causes blood clots. Therefore, it is reckless to continue vaccinating people and loading the body with spike protein, causing more blood clots. According to a paper in Cell (July 2021), the nucleoprotein, not the spike protein, supplied broad and durable immunity for the prevention of infection. The speaker questions why the vaccine wasn't changed to target the nucleoprotein once this information came to light.

The speaker discusses the inflammatory and amyloidogenic effects of small sequences called epitopes, which can cause memory dysfunction in mice. They also mention a study that found the introduction of gene transfection technologies containing the spike protein can induce amyloidogenic cascades. The speaker highlights a 200% increase in the diagnosis of CJD in France after the rollout of vaccination programs, suggesting a potential link. They discuss the loss of cognitive function associated with exposure to the spike protein and propose that amyloidogenic disease processes may underlie long-haul COVID-19 symptoms. The speaker mentions the role of viral infections in facilitating intercellular aggregate dissemination and shares examples of misfolding prion amyloidogenic diseases.

The ACE2 receptor is well-known and plays a crucial role in our bodies. The left side of the chart shows cells lining our blood vessels, which have ACE2 receptors. On the right side, the spike protein from the vaccine affects the mitochondria, the cell's energy source. The spike protein causes fragmentation and damage to the mitochondria. This highlights the contrast between the smooth, intact cells on the left and the disrupted cells on the right, which is a result of the vaccine.

Lipid nanoparticles, not intended for human or veterinary use, were administered to billions of people worldwide. Synthetic RNA from the vaccines persisted for months in the body. The spike protein, found in the brain, peripheral nerves, and organs, caused damage and autoimmune diseases. Spike protein accumulation was also observed in the heart, renal glands, and elastic fibers of the skin. Reproductive harms, such as placental and testicular damage, were reported. The spike protein affected the body's ability to react to other infections and weakened the immune system. It caused damage to blood vessels, including small and large vessels, and led to coronary events and abnormal protein accumulation. The immune system was blinded, leading to a decrease in tumor surveillance and tolerance to pathogens. The video also mentioned the potential impact on cancer.

The video discusses the potential adverse effects of the spike protein in SARS-CoV-2 on human prion protein and amyloid fibril formation. The speaker highlights a study showing that spike amyloid fibrils can accelerate the formation of amyloid fibrils associated with prion diseases and Alzheimer's. They also mention recent research suggesting that other viruses, like H5N1 influenza, may impact and misfold prion protein. The speaker emphasizes the importance of understanding these interactions and their potential implications. They briefly mention the symptoms and diagnostic challenges of prion diseases like Creutzfeldt-Jakob disease. Overall, the video explores the role of the spike protein in amyloidosis and its potential impact on neurological tissues.

The spike protein from the COVID-19 virus circulates in the body and can land in multiple organs, causing various diseases. Lab studies have shown that even without the virus, just injecting the spike protein can induce the same lung, vascular, heart, and brain diseases as COVID-19. The spike protein is considered the toxin responsible for causing the disease. This raises questions about why we are injecting something that is essentially a toxin into the human body, as it is not a traditional vaccine.

The spike and pseudouridine in the shots are changing receptor patterns on cells, suppressing the immune system's ability to fight off viruses like herpes, HPV, and RSV. Toll-like receptors, which train cells to fight cancer, are also being suppressed. These receptors are like the marines of our immune system, constantly circulating and identifying friend or foe. However, the shots are causing these marines, along with dendritic cells and macrophages, to become inactive, leaving the body defenseless against cancer cells and pathogens. It is unclear when this suppression stops or how to reverse it. While not affecting everyone, the degree to which it is happening is concerning.

Bonjour, je suis Anaïs Bocquet, docteur en biologie santé, spécialisée en immunologie. Je vais vous parler du virus SARS-CoV-2 et de sa protéine Spike. Cette protéine est un GOF, clé d'entrée du virus dans l'organisme. Elle présente des propriétés persistantes, bactériophages et cancérogènes. Elle est également amyloïde, fusogène et impacte le système immunitaire. Les injections anti-Covid produisent une protéine Spike similaire à celle du virus, avec les mêmes propriétés. Cela peut causer des problèmes à long terme. Il est important de comprendre comment le virus et la protéine Spike interagissent avec d'autres pathogènes, comme les bactéries. Les questions scientifiques sont nombreuses et nécessitent l'intervention d'experts dans divers domaines. Merci de votre attention. Translation: Hello, I am Anaïs Bocquet, a doctor in health biology, specialized in immunology. I will talk to you about the SARS-CoV-2 virus and its Spike protein. This protein is a GOF, the key to the virus entering the body. It has persistent, bacteriophage, and carcinogenic properties. It is also amyloid, fusogenic, and impacts the immune system. Anti-Covid injections produce a Spike protein similar to that of the virus, with the same properties. This can cause long-term problems. It is important to understand how the virus and the Spike protein interact with other pathogens, such as bacteria. There are many scientific questions that require the intervention of experts in various fields. Thank you for your attention.

Bonjour à tous, Anaïs Bloqué, docteur en biologie santé, explique les impacts de la protéine Spike du SARS-CoV-2 sur le système immunitaire inné, basés sur son article récent. La Spike seule n'active pas complètement le TLR 4, un récepteur immunitaire, et ne produit pas d'interférons de type 1, essentiels pour la réponse antivirale. Pour une activation complète, la Spike doit s'associer au LPS (des bactéries Gram négatif). L'activation des interférons 1 augmente l'expression d'ACE2, le récepteur du virus, via les ISG, sensibilisant l'organisme à l'infection. Les ARN messagers des vaccins peuvent aussi lancer la production d'interférons 1 via MDA5. La Spike, protéine amyloïde, peut aussi déclencher le TLR 4 avec des fibres amyloïdes, entraînant un "double effet amyloïde". L'augmentation de NF-κB par les ISG peut bloquer la p53, potentiellement cancérigène. De plus, NF-κB induit le MIR-200c, qui bloque l'ACE2. Chez les individus avec comorbidités, une boucle d'amplification inflammatoire se crée : Spike-LPS-TLR4 induit interférons 1, ISG, surexpression d'ACE2, augmentation de NF-κB, MIR-200c, diminution d'ACE2 et augmentation d'angiotensine 2. La Spike persiste longtemps, et ses propriétés amyloïdes font craindre des pathologies dégénératives à long terme. --- Hello everyone, Anaïs Bloqué, PhD in health biology, explains the impacts of the SARS-CoV-2 Spike protein on the innate immune system, based on her recent article. Spike alone does not fully activate TLR 4, an immune receptor, and does not produce type 1 interferons, which are essential for the antiviral response. For complete activation, Spike must associate with LPS (from Gram-negative bacteria). Activation of interferon 1 increases the expression of ACE2, the virus's receptor, via ISGs, sensitizing the body to infection. Vaccine mRNAs can also trigger the production of interferon 1 via MDA5. Spike, an amyloid protein, can also trigger TLR 4 with amyloid fibers, leading to a "double amyloid effect." The increase in NF-κB by ISGs can block p53, which is potentially carcinogenic. In addition, NF-κB induces MIR-200c, which blocks ACE2. In individuals with comorbidities, an inflammatory amplification loop is created: Spike-LPS-TLR4 induces interferon 1, ISG, ACE2 overexpression, increased NF-κB, MIR-200c, decreased ACE2 and increased angiotensin 2. Spike persists for a long time, and its amyloid properties raise concerns about long-term degenerative pathologies.

Speaker 1 explains cancer is usually a mutation, and the immune system surveils with 30,000,000 T cells. After vaccination there is suppression of many cell lines. The mRNA shot uses pseudouridine in a lipid nanoparticle to evade the immune system, and it can "hijack your cells, and makes your cells the spike factory." The spike "breaks off of the surface of your cell and goes into circulation." Pseudouridine can cause decrease in certain protein kinase pathways and certain retinoic acid receptor pathways, many things that are responsible for normal cell function and then can lead to mutagenesis as well. Stanford study by Doctor Woltkin et al shows "up to sixty days later, the synthetic mRNA is still in lymph nodes and spike is still circulating." Toll-like receptors downregulated: seven, eight, three, four; Dr. Fossa notes downregulation linked to multiple cancers. Micro RNA array disruption and G protein disruptions are mentioned.

Dr. Michael Palmer, an MD and professor of biochemistry, discusses the mechanisms by which COVID mRNA vaccines can cause toxicity. He identifies four major mechanisms: the spike protein triggering an immune response, toxic activity of the lipid nanoparticles used to deliver the mRNA, toxicity of the spike protein itself, and contamination of the vaccines with DNA. He explains how these mechanisms can lead to inflammation, blood clotting, and other adverse events. Dr. Palmer emphasizes that the immune attack on spike-expressing cells is the main driver of vaccine damage. He concludes that mRNA vaccines are a bad idea and urges support for scientist Sutra At Bakhti, who has faced persecution for speaking out against the vaccines.

Lipid nanoparticles, not intended for human or veterinary use, were administered to billions of people worldwide. Synthetic RNA and spike proteins from the vaccines were found to persist in the body for months, accumulating in the brain, peripheral nerves, liver, and other organs. Autoimmune diseases, myocarditis, renal gland damage, and reproductive harms were also observed. The spike protein affected the immune system, weakened the body's response to other infections, and caused damage to blood vessels, including the coronary vessels. It also led to the accumulation of abnormal proteins in the blood and impaired tumor surveillance. The potential impact on cancer was highlighted as a significant concern.